Movement Alert｜WuXi XDC Falls 3.01% in Regular Trading, Intensive Buybacks Fail to Reverse Sustained Selling Pressure Across WuXi Cluster

Market Focus06-03

On June 3, WuXi XDC fell 3.01% in regular trading, trading at 53.2 HKD/share, with trading volume of approximately 32.21 million HKD. The stock had rebounded for only two trading days before resuming its downward trajectory.

On the news front, the company previously disclosed that its professional trustee purchased 5.702 million shares on the open market between May 19 and 29 at an average price of 57.3 HKD, with total consideration of approximately 327 million HKD funded entirely from internal resources. Additionally, the company announced a proposal to seek shareholder approval at its AGM to authorize buybacks of up to 10% of issued share capital. Combined with parent WuXi Biologics' up-to-400-million-USD buyback plan, the WuXi group's aggregate repurchase scale reaches 500 million USD. Despite these intensive buyback measures, selling pressure persisted across the sector, with WuXi Biologics declining 4.89% and WuXi AppTec falling 2.54%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1158672867?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-03 09:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1158672867","market":"hk","top_or_hot":-1,"title":"Movement Alert｜WuXi XDC Falls 3.01% in Regular Trading, Intensive Buybacks Fail to Reverse Sustained Selling Pressure Across WuXi Cluster","media":"Market Focus","content":"<p><p>On June 3, WuXi XDC fell 3.01% in regular trading, trading at 53.2 HKD/share, with trading volume of approximately 32.21 million HKD. The stock had rebounded for only two trading days before resuming its downward trajectory.</p><p>On the news front, the company previously disclosed that its professional trustee purchased 5.702 million shares on the open market between May 19 and 29 at an average price of 57.3 HKD, with total consideration of approximately 327 million HKD funded entirely from internal resources. Additionally, the company announced a proposal to seek shareholder approval at its AGM to authorize buybacks of up to 10% of issued share capital. Combined with parent WuXi Biologics' up-to-400-million-USD buyback plan, the WuXi group's aggregate repurchase scale reaches 500 million USD. Despite these intensive buyback measures, selling pressure persisted across the sector, with WuXi Biologics declining 4.89% and WuXi AppTec falling 2.54%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi XDC Falls 3.01% in Regular Trading, Intensive Buybacks Fail to Reverse Sustained Selling Pressure Across WuXi Cluster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi XDC Falls 3.01% in Regular Trading, Intensive Buybacks Fail to Reverse Sustained Selling Pressure Across WuXi Cluster\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-03 09:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 3, WuXi XDC fell 3.01% in regular trading, trading at 53.2 HKD/share, with trading volume of approximately 32.21 million HKD. The stock had rebounded for only two trading days before resuming its downward trajectory.</p><p>On the news front, the company previously disclosed that its professional trustee purchased 5.702 million shares on the open market between May 19 and 29 at an average price of 57.3 HKD, with total consideration of approximately 327 million HKD funded entirely from internal resources. Additionally, the company announced a proposal to seek shareholder approval at its AGM to authorize buybacks of up to 10% of issued share capital. Combined with parent WuXi Biologics' up-to-400-million-USD buyback plan, the WuXi group's aggregate repurchase scale reaches 500 million USD. Despite these intensive buyback measures, selling pressure persisted across the sector, with WuXi Biologics declining 4.89% and WuXi AppTec falling 2.54%.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1158672867","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1158672867","pubTimestamp":1780451723,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 3, WuXi XDC fell 3.01% in regular trading, trading at 53.2 HKD/share, with trading volume of approximately 32.21 million HKD. The stock had rebounded for only two trading days before resuming...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"动向提示|无锡XDC常规交易跌3.01%密集回购未能扭转无锡集群持续抛压","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On June 3, WuXi XDC fell 3.01% in regular trading, trading at 53.2 HKD/share, with trading volume of approximately 32.21 million HKD. The stock had rebounded for only two trading days before resuming its downward trajectory.On the news front, the company previously disclosed that its professional trustee purchased 5.702 million shares on the open market between May 19 and 29 at an average price of 57.3 HKD, with total consideration of approximately 327 million HKD funded entirely from internal resources. Additionally, the company announced a proposal to seek shareholder approval at its AGM to authorize buybacks of up to 10% of issued share capital. Combined with parent WuXi Biologics' up-to-400-million-USD buyback plan, the WuXi group's aggregate repurchase scale reaches 500 million USD. Despite these intensive buyback measures, selling pressure persisted across the sector, with WuXi Biologics declining 4.89% and WuXi AppTec falling 2.54%.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1158672867","isCrawlerRequest":true}